Key Insights

Highlights

Success Rate

86% trial completion

Published Results

29 trials with published results (5%)

Research Maturity

204 completed trials (33% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.3%

33 terminated out of 617 trials

Success Rate

86.1%

-0.5% vs benchmark

Late-Stage Pipeline

18%

112 trials in Phase 3/4

Results Transparency

14%

29 of 204 completed with results

Key Signals

29 with results86% success33 terminated

Data Visualizations

Phase Distribution

470Total
Not Applicable (207)
Early P 1 (2)
P 1 (50)
P 2 (99)
P 3 (78)
P 4 (34)

Trial Status

Completed204
Recruiting149
Not Yet Recruiting102
Unknown93
Terminated33
Active Not Recruiting16

Trial Success Rate

86.1%

Benchmark: 86.6%

Based on 204 completed trials

Clinical Trials (617)

Showing 20 of 20 trials
NCT05611242Phase 3RecruitingPrimary

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

NCT07739160Phase 2Not Yet RecruitingPrimary

The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients

NCT06956521Phase 1RecruitingPrimary

Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke

NCT07475949Phase 3RecruitingPrimary

Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging

NCT07361302Phase 3RecruitingPrimary

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

NCT07845903Not Yet RecruitingPrimary

A Prospective Study to Observe Clinical Outcomes in Patients Receiving Antiplatelet or Anticoagulant Therapy for Cancer-Associated Acute Ischemic Stroke

NCT07844603Phase 2CompletedPrimary

Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME)

NCT07843797Not ApplicableNot Yet Recruiting

SAIL-MEVO: Endovascular Treatment Versus Best Medical Therapy for Distal Vessel Occlusions

NCT05756257RecruitingPrimary

Blood Pressure Variability and Ischemic Stroke Outcome

NCT07844096Not ApplicableNot Yet RecruitingPrimary

COOLing of the Ischemic PENumbra in Patients With Acute Ischemic Stroke.

NCT06781385Phase 2Enrolling By InvitationPrimary

Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke

NCT07842185Phase 2Not Yet RecruitingPrimary

A Multicenter, Three-Arm, Open-Label, Endpoint-Blinded Randomized Controlled Trial to Evaluate the Optimal Duration of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic Stroke

NCT07624396RecruitingPrimary

Association Between Circulating BDNF Levels and Cardioembolic Strokes in Patients Treated for Ischemic Stroke

NCT07585058Not ApplicableNot Yet RecruitingPrimary

Safety and Efficacy of Early Non-invasive Brain-Computer Interface-Based Rehabilitation in Acute Ischemic Stroke

NCT06143488Not ApplicableRecruitingPrimary

Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS

NCT07840794Not ApplicableNot Yet RecruitingPrimary

Stimulation-Temperature-Oxygen-Positioning Multimodal Neuroprotection for Acute Ischemic Stroke (STOP)

NCT06139692Phase 4CompletedPrimary

Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke

NCT06548971Phase 3RecruitingPrimary

Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)

NCT06179017Not ApplicableCompleted

Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion

NCT07776873Phase 3Not Yet RecruitingPrimary

Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke

Scroll to load more

Research Network

Activity Timeline